A Structurally Based Approach to Determine HLA Compatibility at the Humoral Immune Level

Human Immunology

Volumn 67, Issue 11, 2006, Pages 847-862

  Duquesnoy, Rene J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

epitope structure; eplet; histocompatibility; HLA; HLAMatchmaker

Indexed keywords

ALLOANTIBODY; AMINO ACID; EPITOPE; HLA ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; CRYSTALLIZATION; HISTOCOMPATIBILITY; HUMORAL IMMUNITY; PRIORITY JOURNAL; SEROLOGY; STEREOCHEMISTRY;

AMINO ACIDS; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; BINDING SITES; EPITOPES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33845914198     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.08.001     Document Type: Article

References (116)

1. Duquesnoy R.J. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 63 (2002) 339
2. Duquesnoy R.J., Takemoto S., De Lange N., et al. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation 75 (2003) 884
3. Boehringer D., Reinhard T., Duquesnoy R., et al. Beneficial effect of matching at the HLA-A and B amino-acid triplet level on rejection free survival in panetrating keratoplasty. Transplantation (2004) 417
4. Laux G., Mytilineos J., and Opelz G. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplanation. Transplantation 77 (2004) 902
5. Duquesnoy R., and Claas F. Is the application of HLAMatchmaker relevant in kidney transplantation?. Transplantation 79 (2005) 250 (Letter.)
6. Haririan A., Fagoaga O., Daneshvar H., Morawski K., Sillix D., El-Amm J., West M., Garnick J., Migdal S., Gruber S., and Nehlsen-Cannarella S. Predictive value of HLA epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort. Clin Transplant 20 (2006) 226
7. Duquesnoy R.J., and Marrari M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol 63 (2002) 353
8. Lobashevsky A.L., Senkbeil R.W., Shoaf J.L., Stephenson A.K., Skelton S.B., Burke R.M., Deierhoi M.H., and Thomas J.M. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. Hum Immunol 63 (2002) 364
9. Dankers M.K.A., Witvliet M.D., Roelen D.L., De Lange P., Korfage N., Persijn G.G., Duquesnoy R.J., Doxiadis I.I.N., and Claas F.H.J. The number of amino acid triplet differences between patient and donor is predicitve for the antibody reactivity against mismatched HLA antigens. Transplantation I28 (2004) 1236
10. Duquesnoy R.J., Witvliet M.J., Doxiadis I.I.N., de Fijter H., and Claas F.H.J. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates. Transplant Int 7 (2004) 31
11. Claas F.H.J., Witvliet M., Duquesnoy R.J., Persijn G., and Doxiadis I.I.N. The acceptable mismatch program as a fast tool to transplant highly sensitized patients awaiting a post-mortal kidney: short waiting time and excellent graft outcome. Transplantation 78 (2004) 190
12. Iniotaki-Theodoraki A., Kalogeropoulou E., Apostolaki M., Doxiadis I., and Stavropoulos-Giokas C. Humoral sensitization against rejected grafts: specific antibodies to graft immunogenic amino acid triplets. Transplant Proc 36 (2004) 1728
13. Varnavidou-Nicolaidou A., Doxiadis I., Iniotaki-Theodoraki A., Patargias T., Stavropoulos-Giokas C., and Kyriakides G. HLA class I donor-specific triplet antibodies detected after renal transplantation. Transplant Proc 36 (2004) 1732
14. Adeyi O., Girnita A., Awadalla Y., Askar M., Shapiro R., Howe J., Martell J., Zeevi A., Nalesnik M., Rhandawa P., Demetris A.J., and Duquesnoy R.J. Serum analysis after kidney transplant nephrectomy reveals restricted antibody specificity patterns against donor HLA class I antigens. Transpl Immunol 14 (2005) 53
15. Doxiadis I.I.N., Duquesnoy R.J., and Claas F.H.J. Extending options for highly sensitized patients to receive a suitable kidney graft. Curr Opin Immunol 17 (2005) 536
16. Goodman R., Taylor C., O'Rourke C., Lynch A., Bradley A., and Key K. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitised patients awaiting kidney transplantation. Transplantation 81 (2006) 1331
17. Nambiar A., Duquesnoy R.J., Adams S., Oblitas J., Leitman S., Stroncek D., and Marincola F. HLAMatchmaker-driven analysis of response to HLA matched platelet transfusions in alloimmunized patients. Blood 107 (2006) 1680
18. Kallon D., Papassavas A.C., Brown C., Duquesnoy R.J., and Navarrete C. The use of HLA epitope mismatches for selection of platelets transfusions in immunologically refractory patients. Submitted (2006)
19. Duquesnoy R., Mulder A., Fernandez-Vina M., Askar M., and Claas F. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 66 (2005) 749
20. Benjamin D.C., Berzofsky J.A., East I.J., Gurd F.R.N., Hannum C., Leach S.J., Margoliash E., Michael J.G., Miller A., Prager E.M., Reichlin M., Sercarz E.E., Smith-Gill S.J., Todd P.E., and Wilson A.C. The antigenic structure of proteins: a reappraisal. Annu Rev Immunol 2 (1984) 67
21. Colman P.M. Structure of antibody-antigen complexes: implications for immune recognition. Adv Immunol 43 (1988) 99
22. Getzoff E.D., Tainer J.A., Lerner R.A., and Geysen H.M. The chemistry and mechanisnm of antibody binding to protein antigens. Adv Immunol 43 (1988) 1
23. Van Regenmortel M.H.V. Structural and functional approaches to the study of protein antigenicity. Immunol Today 10 (1989) 266
24. Hogue C. Cn3D: a new generation of three-dimensional molecular structure viewer. Trends Biochem Sci 22 (1997) 314
25. Altschul S., Madden T., Schäffer A., Zhang J., Zhang Z., Miller W., and Lipman D. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25 (1997) 3389
26. Kabat E.A., Wu T., and Bilofsky H. Unusual distribution of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites. J Biol Chem 252 (1977) 6609
27. Kabat E.A. The structural basis of antibody complementarity. Adv Protein Chem 32 (1978) 1
28. Tonegawa S. Somatic generation of antibody diversity. Nature 302 (1983) 575
29. Chothia C., Lesk A., Tramontano A., Smith-Gill S., Air G., Sheriff S., Padlan E., Davies D., Tulip W., Colman P.M., Spinelli S., Alzari P.M., and Poljak R. Conformation of immunoglobulin hypervariable regions. Nature 342 (1989) 877
30. Wilson I.A., and Stanfield R.L. Antibody-antigen interactions: new structures and new conformational changes. Curr Opin Struct Biol 4 (1994) 857
31. Padlan. EA: Anatomy of the antibody molecule. Mol Immunol 31 (1994) 169
32. Kirkham P.M., and Schroeder Jr. H.W. Antibody structure and the evolution of immunoglobulin V gene segments. Semin Immunol 6 (1994) 347
33. MacCallum R.M., Martin A.C.R., and Thornton J.M. Antibody-antigen interactions: contact analysis and binding site topography. J Mol Biol 262 (1996) 732
34. Zemlin M., Klinger M., Link J., Zemlin C., Bauer K., Englern J., Schroeder Jr. H., and Kirkham P.M. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol 334 (2003) 733
35. Al-Lazikani B., Lesk A., and Chothia C. Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 273 (1997) 927
36. Davies D., Padlan E., and Sheriff S. Antibody-antigen complexes. Annu Rev Biochem 59 (1990) 439
37. Almagro J. Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires. J Mol Recognit 17 (2004) 132
38. Jerne N. Annu Rev Microbiol 14 (1960) 341
39. Laver W.G., Air G.M., Webster R.G., and Smith-Gill S.J. Epitopes on protein antigens: misconception and realities. Cell 61 (1990) 553
40. Sela M.B., Schechter I., and Schechter F. Borek: Antibodies to sequential and conformational determinants. Cold Spring Harbor Symp Quant Biol 32 (1967) 537
41. Atassi M., and Smith J. A proposal for the nomenclature of antigenic sites in peptides and proteins. Immunochemistry 15 (1978) 609
42. Braden B., Goldman E., Mariuzza R., and Poljak R. Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D. Immunol Rev 163 (1998) 45
43. Laune D., Molina K., Ferrieres G., Mani J.-C., Cohen P., Simon D., Bernardi T., Piechaczyk M., Pau B., and Granier C. Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins. J Biol Chem 272 (1997) 30937
44. Van Regenmortel M. Reductionism and the search for structure-function relationships in antibody molecules. J Mol Recognit 15 (2002) 240
45. Novotny J. Protein antigenicity: a thermodynamic approach. Mol Immunol 28 (1991) 201
46. Cunningham B., and Wells J. Comparison of a structural and a functional epitope. J Mol Biol 234 (1993) 554
47. Wells J. Binding in the growth hormone receptor complex. Proc Nat Acad Sci USA 93 (1996) 1
48. Davies D., and Cohen G. Interactions of protein antigens with antibodies. Proc Natl Acad Sci USA 93 (1996) 7
49. DeLano W. Unraveling hot spots in binding interfaces: progress and challenges. Curr Opin Struct Biol 12 (2002) 14
50. Hawkins R., Russell R., Baier M., and Winter G. The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen. The interaction of mutant D1.3 antibodies with lysozyme. J Mol Biol 234 (1993) 958
51. Roberts V., Getzoff E., and Tainer J. Structural basis of antigenic cross-reactivity. In: Van Regenmortel M. (Ed). Structure of Antigens (1993), CRC Press, Boca Raon, FL 31-53
52. Bogan A.A., and Thorn K.S. Anatomy of hot spots in protein interfaces. J Mol Biol 280 (1998) 1
53. Tainer J.T., Getzoff E.D., Paterson Y., Olson A.J., and Lerner R.J. The atomic mobility component of protein antigenicity. Annu Rev lmmunol 3 (1985) 501
54. Cortopassi G.A., and Wilson A.C. Recent origin of the P lysozyme gene in mice. Nucleic Acids Res 18 (1990) 1911
55. Obita T., Ueda T., and Imoto T. Solution structure and activity of mouse lysozyme M. Cell Mol Life Sci 60 (2003) 176
56. Smith-Gill S.J., Lavoie T.B., and Mainhart C. Antigenic regions defined by monoclonal antibodies correspond to structural domains of avian lysozymes. J Immunol 133 (1984) 384
57. Metzger D.W., Ch'ng L.-K., Miller A., and Sercarz E.E. The expressed lysozyme-specific B cell repertoire: 1. Heterogeneity in the monoclonal anti-hen egg white lysozyme specificity repertoire and its difference from the in situ repertoire. Eur J Immunol 14 (1984) 87
58. Harper M., Lema F., Boulot G., and Poljak R.J. Antigen specificity and cross-reactivity of monoclonal anti-lysozyme antibodies. Mol Immunol 2 (1987) 97
59. Newman M., Mainhart C., Mallett C., Lavoie T.B., and Smith-Gill S. Patterns of antibody specificity during the BALB/c immune response to hen eggwhite lysozyme. J Immunol 149 (1992) 3260
60. Amit A., Mariuzza R., Phillips S., and Poljak R. Three-dimensional structure of an antigen-antibody complex at 2.8 Angstrom resolution. Science 233 (1986) 747
61. Fischmann T.O., Bentley G.A., Bhat T.N., Boulot G., Mariuzza R.A., Phillips S.E.V., Tello D., and Poljak R.J. Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-Å; resolution. J Biol Chem 266 (1991) 12915
62. Dall'Acqua W., Goldman E.R., Lin W., Teng C., Tsuchiya D., Li H., Ysern X., Braden B.C., Li Y., Smith-Gill S.J., and Mariuzza R.A. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Biochemistry 37 (1998) 7981
63. Bhat T.N., Bentley G.A., Boulot G., Greene M.I., Tello D., Dall'Acqua W., Souchon H., Schwarz F., Mariuzza R.A., and Poljak R.J. Bound water molecules and conformational stabilization help mediate an antigen-antibody association. Proc Natl Acad Sci USA 91 (1994) 1089
64. Fields B., Goldbaum F.A., Dall'Acqua W., Malchiodi E.L., Cauerhff A., Schwarz F., Ysern X., Poljak R.J., and Mariuzza R.A. Hydrogen bonding and solvent structure in an antigen-antibody interface. Crystal structures and thermodynamic characterization of three Fv mutants complexed with lysozyme. Biochemistry 35 (1996) 15494
65. Carbone F.R., and Paterson Y. Monoclonal antibodies to horse cytochrome c expressing four distinct idiotypes distribute among two sites on the native protein. J Immunol 135 (1985) 2609
66. Bushnell G.W., Louie G.V., and Brayer G.D. High-resolution three-dimensional structure of horse heart cytochrome c. J Mol Biol 214 (1990) 585
67. Mylvaganam S., Paterson Y., and Getzoff E. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 Å resolution and FabE8 to 2.26 Å resolution. J Mol Biol 281 (1998) 301
68. Jemmerson R., and Paterson Y. Mapping antigenic sites on proteins: implications for the design of synthetic vaccines. BioTechniques 4 (1986) 18
69. Cooper H.M., Jemmerson R., Hunt D.F., Griffin P.R., Yates J.R., Shabanowitz J., Zhu N., and Paterson Y. Site-directed chemical modification of horse cytochrome c results in changes in antigenicity due to local and long-range conformational perturbations. J Biol Chem 262 (1987) 11591
70. Duquesnoy R: Structural and functional definitions of epitopes reacting with mouse monoclonal antibodies. HLAMatchmaker Website: http://tpis.upmc.edu, 2006.
71. Akkoc N., and Scornik J. Amino acid residues on HLA molecules critical for alloantibody binding. Transplant Proc 23 (1991) 389
72. McCutcheon J.A., Smith K.D., Valenzuela A., Aalbers K., and Lutz C.T. HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues. Hum Immunol 36 (1993) 69
73. Lutz C.T., Smith K.D., Greazel N.S., Mace B.E., Jensen D.A., McCutcheon J.A., and Goeken N.E. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix. J Immunol 153 (1994) 4099
74. Smith K.D., Kurago Z.B., and Lutz C.T. Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system. Immunol Res 16 (1997) 243
75. Duquesnoy R.J. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. ASHI Quarterly (2002) 60-62
76. Hulsmeyer M., Chames P., Hillig R., Stanfield R., Held G., Coulie P., Alings C., Wille G., Saenger W., Uchanska-Ziegler B., Hoogenboom H., and Ziegler A. A major histocompatibility complex-peptide-restricted antibody and T cell receptor molecules recognize their target by distinct binding modes. Crystal structure of human leukocyte antigen (HLA)-A1 -MAGE-A1 complex with Fab-Hyb3. J Biol Chem 280 (2005) 2972
77. Viken H.D., Paulsen G., Drover S., Marshall W.H., Sollid L.M., Gaudernack G., and Thorsby E. Influence on antibody recognition of amino acid substitutions in the cleft of HLA-DQ2 molecules. Suggestive evidence of peptide-dependent epitopes. Hum Immunol 44 (1995) 63
78. Smith K.D., Mace B.E., Valenzuela A., Vigna J.L., McCutcheon J.A., Barbosa J.A., Huczko E., Engelhard V.H., and Lutz C.T. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. J Immunol 157 (1996) 2470
79. Takamiya Y., Sakaguchi T., Miwa K., and Takiguchi M. Role of HLA-B*5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope. Int Immunol 8 (1996) 1027
80. Mulder M., Eijsink C., Kester M.G.D., Franke M.E.I., Kardol M.J., Heemskerk M.H.M., van Kooten C., Verreck F.A., Drijfhout J.W., Koning F., Doxiadis I.N., and Claas F.J.H. Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies. J Immunol 175 (2005) 5950
81. Ways J.P., Rothbard J.B., and Parham P. Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17. J Immunol 137 (1986) 217
82. Hildebrand W.H., Domena J.D., Shen S.Y., Lau M., Terasaki P.I., Bunce M., Marsh S.G., Guttridge M.G., Bias W.B., and Parham P. HLA-B15: a widespread and diverse family of HLA-B alleles. Tissue Antigens 43 (1994) 209
83. Marsh S.G., and Bodmer J.G. HLA-DR and -DQ epitopes and monoclonal antibody specificity. Immunology Today 10 (1989) 305
84. Klohe E., Fu X.T., Ballas M., and Karr R.W. HLA-DR beta chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes. Human Immunol 37 (1993) 51
85. Drover S., Marshall W.H., Kwok W.W., Nepom G.T., and Karr R.W. Amino acids in the peptide-binding groove influence an antibody-defined, disease-associated HLA-DR epitope. Scand J Immunol 39 (1994) 539
86. Fu X.-T., Drover S., Marshall W.H., and Karr R.W. HLA-DR residues accessible under the peptide-binding groove contribute to polymorphic antibody epitopes. Hum Immunol 43 (1995) 243
87. Akkoc N., and Scornik J.C. HLA epitope matching. Contribution of matched residues to epitopes recognized by alloantibodies. Transplantation 52 (1991) 90
88. McCutcheon J.A., and Lutz C.T. Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies. Human Immunol 35 (1992) 12
89. Smith K.D., and Lutz C.T. Alloreactive T cell recognition of MHC class I molecules. The T cell receptor interacts with limited regions of the MHC class I long alpha helices. J Immunol 158 (1997) 2805
90. Muller C.A., Engler-Blum G., Gekeler V., Steiert I., Weiss E., and Schmidt H. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics 30 (1989) 200
91. Adams E.J., Martinez-Naves E., Arnett K.L., Little A.M., Tyan D.B., and Parham P. HLA-B16 antigens: sequence of the ST-16 antigen, further definition of two B38 subtypes and evidence for convergent evolution of B*3902. Tissue Antigens 45 (1995) 18
92. Nosek J., Hinzova E., and Vorlicek J. Quantitative estimation of HLA-A and HLA-B antigens carrying the Bw4 supertypic specificity in human peripheral blood lymphocytes. Immunogenetics 26 (1987) 273
93. Fuller T.C., and Fuller A. The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder. Transplantation 68 (1999) 173
94. Duquesnoy RJ, Claas FHJ: Progress Report of 14th International Histocompatibility Workshop Project on the Structural Basis of HLA Compatibility. Tissue Antigens (in press).
95. Bhat T.N., Bentley G.A., Fischmann T.O., Boulot G., and Poljak R.J. Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding. Nature 347 (1990) 483
96. Novotny J., Bruccolery R.E., and Saul F.E. On the attribution of binding energy in antigen-antibody complexes McPC603, D1.3, and HyHEL-5. Biochemistry 28 (1989) 4735
97. England P., Bregegere F., and Bedouelle H. Energetic and kinetic contributions of contact residues of antibody D1.3 in the interaction with lysozyme. Biochemistry 36 (1997) 164
98. Shick K., Xavier K., Rajpal A., Smith-Gill S.J., and Willson R. Association of the anti-hen egg lysozyme antibody HyHEL-5 with avian species variant and mutant lysozymes. Biochim Biophys Acta 1340 (1997) 205
99. Sheriff S., Silverton E.W., Padlan E.A., Cohen G.H., Smith-Gill S.J., Finzel B.C., and Davies D.R. Three-dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci USA 84 (1987) 8075
100. Lavoie T.B., Drohan W.N., and Smith-Gill S.J. Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. J Immunol 148 (1992) 503
101. Chacko S., Silverton E., Kam-Morgan L., Smith-Gill S., Cohen G.H., and Davies D. Structure of an antibody-lysozyme complex unexpected effect of a conservative mutation. J Mol Biol 245 (1995) 261
102. Li Y., Li H., Smith-Gill S., and Mariuzza R. Three-dimensional structures of the free and Antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63. Biochemistry 39 (2000) 6296
103. Li Y., Huang Y.M., Swaminathan C., Smith-Gill S.J., and Mariuzza R.A. Magnitude of the hydrophobic effect at central versus peripheral sites in protein-protein interfaces. Structure 13 (2005) 297
104. Li Y., Urrutia M., Smith-Gill S.J., and Mariuzza R.A. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen. Biochemistry 42 (2003) 11
105. Aguet M., and Merlin G. Purification of human γ interferon receptors by sequential affinity chromatography on immobilized monoclonal antireceptor antibodies and human g interferon. J Exp Med 165 (1987) 988
106. Sogabe S., Stuart F., Henke C., Bridges A., Williams G., Birch A., Winkler F.K., and Robinson J.A. Neutralizing epitopes on the extracellular Interferon γ receptor (IFNγR) α-chain characterized homolog scanning mutagenesis and x-ray crystal structure of the A6 Fab-IFNγR1-108 complex. J Mol Biol 273 (1997) 882
107. Gray P.W., Leong S., Fennie E.H., Farrar M.A., Pingel J.T., Fernandez-Luna J., and Schreiber R.D. Cloning and expression of the cDNA for the murine interferon gamma receptor. Proc Natl Acad Sci USA 86 (1989) 8497
108. Mylvaganam S.E., Paterson Y., Kaiser K., Bowdish K., and Getzoff E.D. Biochemical implications from the variable gene sequences of an anti-cytochrome c antibody and crystallographic characterization of its antigen-binding fragment in free and antigen-complexed forms. J Mol Biol 221 (1991) 455
109. Collawn J.F., Wallace C.J.A., Proudfoot A.E.I., and Paterson Y. Monoclonal antibodies as probes of conformational changes in protein-engineered cytochrome c. J Biol Chem 263 (1988) 8625
110. Pons J., Stratton J., and Kirsch J. How do two unrelated antibodies, HyHEL-10 and F9.13.7, recognize the same epitope of hen egg-white lysozyme?. Protein Sci 11 (2002) 2308
111. Lescar J., Pellegrini M., Souchon H., Tello D., Poljak R.J., Peterson N., Greene M., and Alzari P.M. Crystal structure of a cross-reaction complex between Fab F9.13.7 and guinea fowl lysozyme. J Biol Chem 270 (1995) 18067
112. Sinha N., Mohan S., Lipschultz C., and Smith-Gill S. Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity. Biophys J 83 (2002) 2946
113. Kam-Morgan L.N.W., Smith-Gill S.J.T., Taylor M.G., Zhang L., Wilson A.C., and Kirsch J.F. High resolution mapping of the HyHEL-10 epitope of chicken lysozyme by site-directed mutagenesis. Proc Nat Acad Sci 90 (1993) 3958
114. Padlan E.A., Silverton E.W., Sheriff S., Cohen G.H., Smith-Gill S.J., and Davies D.R. Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Nat Acad Sci USA 6 (1989) 5938
115. Kondo H., Shiroishi M., Matsushimai M., Tsumoto K., and Kumagai I. Crystal structure of anti-hen egg white lysozyme antibody (HyHEL-10) Fv-antigen complex. J Biol Chem 274 (1999) 27623
116. Pons J., Rajpal A., and Kirsch J.F. Energetic analysis of an antigen/antibody interface: alanine scanning mutagenesis and double mutant cycles on the HyHEL-10/lysozyme interaction. Protein Sci 8 (1999) 958